Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001582746-19-000001
Filing Date
2019-02-11
Accepted
2019-02-11 17:14:04
Documents
1
Effectiveness Date
2019-02-11
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13381
  Complete submission text file 0001582746-19-000001.txt   14716
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-332606 | Film No.: 19586488
SIC: 2834 Pharmaceutical Preparations